Filing Details
- Accession Number:
- 0001391127-20-000030
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-21 17:00:39
- Reporting Period:
- 2020-02-19
- Accepted Time:
- 2020-02-21 17:00:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1391127 | Limelight Networks Inc. | LLNW | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1351411 | T Jeffrey Fisher | C/O Limelight Networks, Inc. 1465 North Scottsdale Road, Suite 400 Scottsdale AZ 85257 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-19 | 20,000 | $4.00 | 342,231 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-19 | 20,000 | $5.60 | 322,231 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-02-20 | 23,087 | $4.77 | 345,318 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-20 | 23,087 | $6.00 | 322,231 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-02-20 | 34,025 | $2.40 | 356,256 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-20 | 34,025 | $6.00 | 322,231 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-02-20 | 36,406 | $2.39 | 358,637 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-20 | 36,406 | $6.00 | 322,231 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-02-20 | 33,559 | $2.69 | 355,790 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-20 | 33,559 | $6.00 | 322,231 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-02-20 | 26,271 | $4.10 | 348,502 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-20 | 26,271 | $6.00 | 322,231 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Acquisiton | 2020-02-19 | 20,000 | $0.00 | 20,000 | $4.00 |
| Common Stock | Employee Stock Option (Right to Buy) | Acquisiton | 2020-02-20 | 23,087 | $0.00 | 23,087 | $4.77 |
| Common Stock | Employee Stock Option (Right to Buy) | Acquisiton | 2020-02-20 | 34,025 | $0.00 | 34,025 | $2.40 |
| Common Stock | Employee Stock Option (Right to Buy) | Acquisiton | 2020-02-20 | 36,406 | $0.00 | 36,406 | $2.39 |
| Common Stock | Employee Stock Option (Right to Buy) | Acquisiton | 2020-02-20 | 33,559 | $0.00 | 33,559 | $2.69 |
| Common Stock | Employee Stock Option (Right to Buy) | Acquisiton | 2020-02-20 | 26,271 | $0.00 | 26,271 | $4.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-06-10 | No | 4 | M | Direct | |
| 0 | 2021-06-09 | No | 4 | M | Direct | |
| 0 | 2022-06-07 | No | 4 | M | Direct | |
| 0 | 2023-06-06 | No | 4 | M | Direct | |
| 0 | 2024-06-05 | No | 4 | M | Direct | |
| 0 | 2025-06-04 | No | 4 | M | Direct |
Footnotes
- Exercise of reporting person's stock options that would otherwise expire June 10, 2020 of which shares were sold to pay the exercise price, and broker fees and commissions, pursuant to a broker-assisted sell-to-cover order. Exercise was exercised pursuant to 10b5-1 plan adopted on November 20, 2019.
- Price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions, and the range of sale prices for the transactions reported was $5.44 to $5.67. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or any staff member of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each separate price.
- This includes 45,692 unvested restricted stock units.
- Exercise of reporting person's stock options that would otherwise expire June 9, 2021 of which shares were sold to pay the exercise price, and broker fees and commissions, pursuant to a broker-assisted sell-to-cover order. Exercise was exercised pursuant to 10b5-1 plan adopted on November 20, 2019.
- Exercise of reporting person's stock options that would otherwise expire June 7, 2022 of which shares were sold to pay the exercise price, and broker fees and commissions, pursuant to a broker-assisted sell-to-cover order. Exercise was exercised pursuant to 10b5-1 plan adopted on November 20, 2019.
- Exercise of reporting person's stock options that would otherwise expire June 6, 2023 of which shares were sold to pay the exercise price, and broker fees and commissions, pursuant to a broker-assisted sell-to-cover order. Exercise was exercised pursuant to 10b5-1 plan adopted on November 20, 2019.
- Exercise of reporting person's stock options that would otherwise expire June 5, 2024 of which shares were sold to pay the exercise price, and broker fees and commissions, pursuant to a broker-assisted sell-to-cover order. Exercise was exercised pursuant to 10b5-1 plan adopted on November 20, 2019.
- Exercise of reporting person's stock options that would otherwise expire June 4, 2025 of which shares were sold to pay the exercise price, and broker fees and commissions, pursuant to a broker-assisted sell-to-cover order. Exercise was exercised pursuant to 10b5-1 plan adopted on November 20, 2019.
- All such options have fully vested.
Billionaire Hedge Funds
